Skip to content
PubMed This is a summary of 58 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 58 referenced papers

Top Authors

Amy P. Hsu
National Institutes of Health
Despina Moshous
Hôpital Necker-Enfants Malades
Steven M. Holland
National Institutes of Health
Ágnes Donkó
National Institutes of Health
Alain Fischer
Hôpital Necker-Enfants Malades
Thomas L. Leto
National Institutes of Health
James Duncan Chalmers
University of Dundee
Andrew Richard Gennery
Great North Children's Hospital
Mary Anne Slatter
Great North Children's Hospital
Bénédicte Neven
Hôpital Necker-Enfants Malades

Top Institutions

Ranked by publications Top 10 institutions
04

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology

Moscow, Russia

30 papers

References

References (58)
  1. 1

    Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment.

    Feghoul L, Chevret S, Cuinet A, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015; (21(7)):701-9.

    PMID: 25882354
  2. 2

    Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.

    Balashov D, Shcherbina A, Maschan M, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015; (21(11)):1955-62.

    PMID: 26187864
  3. 3

    Optical Tools To Study the Isoform-Specific Roles of Small GTPases in Immune Cells.

    Miskolci V, Wu B, Moshfegh Y, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2016; (196(8)):3479-93 doi:10.4049/jimmunol.1501655.

    PMID: 26951800
  4. 4

    Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.

    Hill AT, Haworth CS, Aliberti S, et al.

    The European respiratory journal 2017; (49(6)) doi:10.1183/13993003.00051-2017.

    PMID: 28596426
  5. 5

    Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patients.

    Nagasawa M, Mitsuiki N, Aoki Y, et al.

    European journal of haematology 2017; (99(6)):525-531 doi:10.1111/ejh.12967.

    PMID: 28888028
  6. 6

    Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience.

    Slatter MA, Rao K, Abd Hamid IJ, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018; (24(3)):529-536 doi:10.1016/j.bbmt.2017.11.009.

    PMID: 29155317
  7. 7

    Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland.

    Edgar JDM, Richter AG, Huissoon AP, et al.

    Journal of clinical immunology 2018; (38(2)):204-213 doi:10.1007/s10875-017-0469-4.

    PMID: 29423883
  8. 8

    Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

    Maccari ME, Abolhassani H, Aghamohammadi A, et al.

    Frontiers in immunology 2018; (9()):543 doi:10.3389/fimmu.2018.00543.

    PMID: 29599784
  9. 9

    Macrophage Rac2 Is Required to Reduce the Severity of Cigarette Smoke-induced Pneumonia.

    Larson-Casey JL, Gu L, Jackson PL, et al.

    American journal of respiratory and critical care medicine 2018; (198(10)):1288-1301 doi:10.1164/rccm.201712-2388OC.

    PMID: 29897791
  10. 10

    Management of bronchiectasis in adults.

    Visser SK, Bye P, Morgan L

    The Medical journal of Australia 2018; (209(4)):177-183 doi:10.5694/mja17.01195.

    PMID: 30107772
  11. 11

    Primary immunodeficiency.

    McCusker C, Upton J, Warrington R

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14(Suppl 2)):61 doi:10.1186/s13223-018-0290-5.

    PMID: 30275850
  12. 12

    Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.

    Wasserman RL

    Immunology and allergy clinics of North America 2019; (39(1)):95-111 doi:10.1016/j.iac.2018.08.001.

    PMID: 30466775
  13. 13

    Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.

    Ferrua F, Galimberti S, Courteille V, et al.

    The Journal of allergy and clinical immunology 2019; (143(6)):2238-2253 doi:10.1016/j.jaci.2018.12.1010.

    PMID: 30660643
  14. 14

    Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.

    Hsu AP, Donkó A, Arrington ME, et al.

    Blood 2019; (133(18)):1977-1988 doi:10.1182/blood-2018-11-886028.

    PMID: 30723080
  15. 15

    Early high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: A before-after study.

    Macé J, Marjanovic N, Faranpour F, et al.

    The American journal of emergency medicine 2019; (37(11)):2091-2096 doi:10.1016/j.ajem.2019.03.004.

    PMID: 30857910
  16. 16

    Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections.

    Sharapova SO, Haapaniemi E, Sakovich IS, et al.

    Clinical immunology (Orlando, Fla.) 2019; (205()):1-5 doi:10.1016/j.clim.2019.05.003.

    PMID: 31071452
  17. 17

    Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders.

    Gavrilova T

    World journal of transplantation 2019; (9(3)):48-57 doi:10.5500/wjt.v9.i3.48.

    PMID: 31392129
  18. 18

    Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.

    Chalmers JD, Boersma W, Lonergan M, et al.

    The Lancet. Respiratory medicine 2019; (7(10)):845-854 doi:10.1016/S2213-2600(19)30191-2.

    PMID: 31405828
  19. 19

    Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

    Dimitrova D, Gea-Banacloche J, Steinberg SM, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2020; (26(1)):94-106 doi:10.1016/j.bbmt.2019.08.018.

    PMID: 31493539
  20. 20

    Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.

    Laberko A, Sultanova E, Gutovskaya E, et al.

    Blood 2019; (134(20)):1755-1763 doi:10.1182/blood.2019001757.

    PMID: 31558465
  21. 21

    Hot topics and current controversies in non-cystic fibrosis bronchiectasis.

    Severiche-Bueno D, Gamboa E, Reyes LF, Chotirmall SH

    Breathe (Sheffield, England) 2019; (15(4)):286-295 doi:10.1183/20734735.0261-2019.

    PMID: 31803263
  22. 22

    Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT.

    Neven B, Ferrua F

    Frontiers in pediatrics 2019; (7()):552 doi:10.3389/fped.2019.00552.

    PMID: 32039114
  23. 23

    Effectiveness of chest physiotherapy and pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a narrative review.

    Annoni S, Bellofiore A, Repossini E, et al.

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2020; (90(1)) doi:10.4081/monaldi.2020.1107.

    PMID: 32072797
  24. 24

    The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.

    Arrington ME, Temple B, Schaefer A, Campbell SL

    The Journal of biological chemistry 2020; (295(34)):12130-12142 doi:10.1074/jbc.RA120.012915.

    PMID: 32636302
  25. 25

    The challenges presented by haematopoietic stem cell transplantation in children with primary immunodeficiency.

    Gennery AR

    British medical bulletin 2020; (135(1)):4-15 doi:10.1093/bmb/ldaa017.

    PMID: 32676650
  26. 26

    Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong Kong.

    Kwok JSY, Cheung SKF, Ho JCY, et al.

    Frontiers in immunology 2020; (11()):1411 doi:10.3389/fimmu.2020.01411.

    PMID: 32765500
  27. 27

    Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.

    Dorsey MJ, Wright NAM, Chaimowitz NS, et al.

    Journal of clinical immunology 2021; (41(1)):38-50 doi:10.1007/s10875-020-00865-9.

    PMID: 33006109
  28. 28

    Inborn Errors of Immunity: how to diagnose them?

    Grumach AS, Goudouris ES

    Jornal de pediatria 2021; (97 Suppl 1()):S84-S90 doi:10.1016/j.jped.2020.11.007.

    PMID: 33400918
  29. 29

    Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III.

    Bakhtiar S, Salzmann-Manrique E, Blok HJ, et al.

    Blood advances 2021; (5(1)):262-273 doi:10.1182/bloodadvances.2020002185.

    PMID: 33570653
  30. 30

    Inborn Errors of Immunity and Cancer.

    Tiri A, Masetti R, Conti F, et al.

    Biology 2021; (10(4)) doi:10.3390/biology10040313.

    PMID: 33918597
  31. 31

    High flow nasal cannula for adult acute hypoxemic respiratory failure in the ED setting.

    Long B, Liang SY, Lentz S

    The American journal of emergency medicine 2021; (49()):352-359 doi:10.1016/j.ajem.2021.06.074.

    PMID: 34246166
  32. 32

    Diagnostic Modalities in Primary Immunodeficiency.

    Raymond LS, Leiding J, Forbes-Satter LR

    Clinical reviews in allergy & immunology 2022; (63(1)):90-98 doi:10.1007/s12016-022-08933-1.

    PMID: 35290615
  33. 33

    Homing of granulocytes transfused in perineal cellulitis in a RAC2 deficiency child monitored by chimerism quantification methods.

    Pedini P, Sterin A, Clapasson C, Picard C

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2022; (29(3)):265-268 doi:10.1016/j.tracli.2022.03.002.

    PMID: 35331893
  34. 34

    Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.

    Zhang L, Chen Z, Li W, et al.

    Journal of clinical immunology 2022; (42(6)):1280-1292 doi:10.1007/s10875-022-01288-4.

    PMID: 35596857
  35. 35

    Hyper-IgE and Carcinoma in CADINS Disease.

    Pietzsch L, Körholz J, Boschann F, et al.

    Frontiers in immunology 2022; (13()):878989 doi:10.3389/fimmu.2022.878989.

    PMID: 35651609
  36. 36

    Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.

    Quinn J, Modell V, Johnson B, et al.

    Frontiers in immunology 2022; (13()):906540 doi:10.3389/fimmu.2022.906540.

    PMID: 35757720
  37. 37

    Hemoptysis and the Risk for Lung Transplant or Death without Transplant in Individuals with Cystic Fibrosis in the United States.

    Bayomy OF, Ramos KJ, Hee Wai T, et al.

    Annals of the American Thoracic Society 2022; (19(12)):1986-1992 doi:10.1513/AnnalsATS.202202-110OC.

    PMID: 35759341
  38. 38

    A Novel RAC2 Mutation Causing Combined Immunodeficiency.

    Zhang L, Lv G, Peng Y, et al.

    Journal of clinical immunology 2023; (43(1)):229-240 doi:10.1007/s10875-022-01373-8.

    PMID: 36190591
  39. 39

    Novel Loss of Function (G15D) Mutation on RAC2 in a Family with Combined Immunodeficiency and Increased Levels of Immunoglobulin G, A, and E.

    Duan X, Shen F, Deng Y, et al.

    Journal of clinical immunology 2023; (43(3)):604-614 doi:10.1007/s10875-022-01411-5.

    PMID: 36459342
  40. 40

    Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand.

    Chang AB, Bell SC, Byrnes CA, et al.

    Respirology (Carlton, Vic.) 2023; (28(4)):339-349 doi:10.1111/resp.14479.

    PMID: 36863703
  41. 41

    Clinical and functional spectrum of RAC2-related immunodeficiency.

    Donkó Á, Sharapova SO, Kabat J, et al.

    Blood 2024; (143(15)):1476-1487 doi:10.1182/blood.2023022098.

    PMID: 38194689
  42. 42

    Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.

    Conceição M, Shteinberg M, Goeminne P, et al.

    European respiratory review : an official journal of the European Respiratory Society 2024; (33(171)) doi:10.1183/16000617.0178-2023.

    PMID: 38296344
  43. 43

    Effect of allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease in children: A multicentre, retrospective cohort study in China.

    Si Y, Dou Y, Zhai X, et al.

    Clinical immunology (Orlando, Fla.) 2024; (260()):109919 doi:10.1016/j.clim.2024.109919.

    PMID: 38309448
  44. 44

    Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.

    Ashby L, Chan L, Winterbourn C, et al.

    Clinical & translational immunology 2024; (13(2)):e1493 doi:10.1002/cti2.1493.

    PMID: 38410820
  45. 45

    Case Report: Profound newborn leukopenia related to a novel RAC2 variant.

    Hall G, Donkó Á, Pratt C, et al.

    Frontiers in pediatrics 2024; (12()):1365187 doi:10.3389/fped.2024.1365187.

    PMID: 38516355
  46. 46

    The Dark Side of Activated Phosphoinositide 3-Kinase-δ Syndrome 2: A Story Rewritten through FDG-PET.

    Catelli A, Nanni C, Mulè R, et al.

    Journal of clinical medicine 2024; (13(8)) doi:10.3390/jcm13082203.

    PMID: 38673479
  47. 47

    Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives.

    Kobayashi RH, Maltese J, Litzman J, et al.

    Immunotherapy 2024; (16(20-22)):1235-1245 doi:10.1080/1750743X.2024.2436343.

    PMID: 39648657
  48. 48

    Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations.

    DeBortoli E, McInerney-Leo A, Macintosh R, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(8)):1918-1927 doi:10.1016/j.jaip.2025.03.052.

    PMID: 40252833
  49. 49

    Targeting Complex Cutaneous Viral Infections in Search of Inborn Errors of Immunity.

    Do Carmo AP, Battle AR, Fragnan NTML, et al.

    Acta dermato-venereologica 2025; (105()):adv41318 doi:10.2340/actadv.v105.41318.

    PMID: 40488587
  50. 50

    Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series.

    Costagliola G, De Marco E, Consonni F, et al.

    Annals of hematology 2025; (104(6)):3117-3127 doi:10.1007/s00277-025-06456-1.

    PMID: 40553169
  51. 51

    Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.

    Roberti G, Maestrini G, Polito B, et al.

    Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176295.

    PMID: 40944054
  52. 52

    Immunoglobulin G Trough Levels and Infection Risk in Adults with Inborn Errors of Immunity Receiving Immunoglobulin Therapy.

    Aktaş ÖÖ, Özer NO, Kaplankıran C, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(9)) doi:10.3390/medicina61091549.

    PMID: 41010940
  53. 53

    Epidemiology and management of malignancies in patients with inborn errors of immunity-An ESID registry study of 19,959 patients.

    Bogaert DJA, Wolfsberger CH, Attarbaschi A, et al.

    The Journal of allergy and clinical immunology 2026; (157(3)):739-753 doi:10.1016/j.jaci.2025.10.033.

    PMID: 41242640
  54. 54

    Case Report: Human metapneumovirus infection leading to septic shock in an adult with COPD and morbid obesity.

    Virzì F, Giacopelli G, Tutone P, et al.

    Frontiers in medicine 2025; (12()):1735031 doi:10.3389/fmed.2025.1735031.

    PMID: 41488075
  55. 55

    [Non-invasive respiratory support for acute respiratory failure with focus on high-flow oxygen therapy and non-invasive Ventilation].

    Fisser C, Malfertheiner M, Lepper PM, Mang S

    Pneumologie (Stuttgart, Germany) 2026; (80(7)):493-499 doi:10.1055/a-2776-7023.

    PMID: 41565209
  56. 56

    Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency.

    Desjardins A, Marois L, Donkó Á, et al.

    Frontiers in immunology 2026; (17()):1723142 doi:10.3389/fimmu.2026.1723142.

    PMID: 41685306
  57. 57

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.

    Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.

    PMID: 42676356
  58. 58

    Functional Clinical Flow Cytometry Assays to Assess Lymphocyte Proliferation, Neutrophil Oxidative Burst, and Leukocyte Adhesion Deficiency Immune Defects.

    Cornaby C, O'Gorman MR

    Current protocols 2026; (6(10)):e70462 doi:10.1002/cpz1.70462.

    PMID: 42873557